MITF-M dimer binds the BIRC7 promoter

Stable Identifier
R-HSA-9857359
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
MITF-M binds to two consensus elements in the promoter of the BIRC7 gene in melanoma cell lines as assessed by ChIP and EMSA (Dynek et al, 2008; Strub et al, 2011). Stimulation of MITF-M with cAMP in melanocytes also causes upregulation of BIRC7 mRNA and protein levels (Dynek et al, 2008). BIRC7 is an anti-apoptotic protein, and consistent with this, melanoma cells show lower survival when MITF expression is ablated with siRNA (Dynek et al, 2008; reviewed in Saleem et al, 2013; Liu et al, 2007; Goding and Arnheiter, 2019).
Literature References
PubMed ID Title Journal Year
17218055 Livin/ML-IAP as a new target for cancer treatment

Wang, L, Wen, JK, Han, M, Liu, B

Cancer Lett 2007
21258399 Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

Ye, T, Cormont, M, Keime, C, Kobi, D, Davidson, I, Le Gras, S, Giuliano, S, Bonet, C, Bertolotto, C, Ballotti, R, Strub, T

Oncogene 2011
31123060 MITF-the first 25 years

Arnheiter, H, Goding, CR

Genes Dev 2019
23790005 Inhibitors of apoptotic proteins: new targets for anticancer therapy

Qadir, MI, Perveen, N, Saleem, U, Saleem, M, Ahmad, B, Ahmad, B, Irshad, T

Chem Biol Drug Des 2013
18451137 Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas

Dynek, JN, Zha, J, Fairbrother, WJ, Vucic, D, Liu, J, Chan, SM

Cancer Res 2008
Participants
Participates
Authored
Reviewed
Created
Cite Us!